Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Revitol Cellulite Cream

Lilly Receives Fourth FDA Approval For ALIMTA(R) - First Chemotherapy Approved As Maintenance Therapy For Nonsquamous Non-Small Cell Lung Cancer
Eli Lilly and Company (NYSE: LLY) announced it received a fourth approval from the U.S. Food and Drug Administration (FDA) for ALIMTA® (pemetrexed for injection). The latest approval is for ALIMTA as a maintenance therapy for locally advanced or metastatic non-small cell lung cancer (NSCLC), specifically for patients with a nonsquamous histology whose disease has not progressed after four cycles of platinum-based first-line chemotherapy. ALIMTA is not indicated for treatment of patients with squamous cell non-small cell lung cancer. Don't forget to buy zoloft online no prescription.

Black Religious Leaders Urging Passage Of HIV/AIDS Bill
Black religious leaders across the country are urging the passage of a bill (H.R. 1964) that would provide more than $600 million in funding for faith-based prevention, testing and outreach programs, the St. Petersburg Times reports. The bill, named the National Black Clergy for the Elimination of HIV/AIDS Act of 2009, calls for programs targeting specific populations within the black community, including young people, substance users and inmates, among others. The bill, introduced in Congress this spring, has been referred to the House Committee on Energy and Commerce (Zayas, St. Petersburg Times, 6/1).

generic viagra online


News of the day
Youths Use Drink Labels To Choose Strongest Drink At Lowest Cost, Australia
Contrary to the industry"s position that visible drink labels will promote responsible drinking, young people are, instead, using these visible standard drink labels to increase or even maximize the amount of alcohol they consume at the lowest cost possible.
Sexual Health

Philips Introduces Three New Products To Improve Performance And Patient Comfort For Hospital And Home Ventilation

Royal Philips Electronics (NYSE: PHG, AEX: PHI) introduced three new respiratory support devices: the Respironics V60 and V200, and Trilogy100 ventilators. These ventilation solutions are intended to support breathing in the intensive care, sub-acute, and home care settings. As a family of products, the three devices are well-suited to address the ventilation care challenges that clinicians face on a daily basis, such as treating respiratory failure from exacerbations of chronic obstructive pulmonary disease (COPD) while avoiding ventilator-associated pneumonia. Respironics V60 Ventilator Following its acquisition of Respironics, Philips extends its recognized leadership in noninvasive ventilation (NIV) with the Respironics V60 Ventilator. It provides traditional invasive respiratory support with a tube inserted into the patient"s windpipe or noninvasive support via a patient face mask. "Noninvasive ventilation has been proven to significantly reduce the incidence of ventilator-associated pneumonia (VAP), and it has also been shown to shorten the time patients spend in the hospital," says Randy Whitfield, general manager of Hospital Respiratory Care, for Philips Healthcare. Respironics V200 Critical Care Ventilator The Respironics V200 Critical Care Ventilator, scheduled for release in June 2009, integrates auto-adaptive technology and provides ventilation for neonatal, pediatric and adult patients. The innovative speaking mode, found on only the Respironics V200 and Esprit ventilators, provides the tracheostomized patient the ability to speak without the need for costly external valves. Ryan Zumalt, director of Respiratory Care at Northern California Rehab Hospital, says, "The speaking mode really boosts the confidence of the patient, making them more apt to progress through the day and work with physical therapy, nursing, and respiratory therapy." Trilogy100 Ventilator Trilogy100 is a highly-versatile, lightweight (11 lbs.) life-support ventilator that meets the needs of a wide range of patients in the home and alternative care settings. Trilogy100 has many advanced features, such as auto-adaptive technology, volume- or pressure- control ventilation and the ability to ventilate with either a mask or a tracheal tube. "Trilogy100 has been designed to help caregivers and clinicians more easily administer care in the home and allow patients to be as active as possible while using the ventilator," says John Frank, vice president and general manager, Home Respiratory Care, for Philips Healthcare. "Its ease of use, versatility, and portability make Trilogy100 a significant advancement in home respiratory support." Royal Philips Electronics


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009